Related Experiment Videos
Optimization and application of the group I ribozyme trans-splicing reaction
Christer Einvik1, Tonje Fiskaa, Eirik W Lundblad
1Department of Molecular Biotechnology--RNA Research Group, Institute of Medical Biology, University of Tromsø, Norway.
Methods in Molecular Biology (Clifton, N.J.)
|March 16, 2004
Summary
Group I ribozymes are catalytic RNAs that can be engineered for gene therapy. Optimized protocols demonstrate their use in mapping target messenger RNA and repairing mutations for therapeutic applications.
Area of Science:
- Molecular Biology
- Biochemistry
- RNA Catalysis
Background:
- Group I ribozymes are naturally occurring catalytic RNAs.
- They can excise introns and ligate exons.
- Engineered ribozymes can act in trans for sequence-specific RNA modification.
Purpose of the Study:
- To describe optimized protocols for using trans-splicing group I ribozymes.
- To demonstrate applications in mapping accessible sites in target messenger RNA (mRNA).
- To showcase utility in mRNA repair by correcting mutations.
Main Methods:
- Engineering of group I ribozymes for trans-splicing activity.
- Application of ribozymes for sequence-specific recognition and covalent linkage to target RNA.
- Utilizing ribozyme transesterification for mRNA site mapping and mutation correction.
Main Results:
- Detailed, optimized protocols for trans-splicing group I ribozyme applications are presented.
- Demonstrated efficacy in mapping accessible sites on target messenger RNA.
- Successful correction of mutations through messenger RNA repair using ribozymes.
Conclusions:
- Trans-splicing group I ribozymes offer a versatile tool for molecular biology applications.
- These ribozymes show significant potential as a novel approach in gene therapy.
- Optimized protocols facilitate precise mRNA targeting and repair, advancing therapeutic strategies.